…
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ecolab Inc provides water, hygiene and infection-prevention products and services to foodservice, healthcare, industrial and energy customers worldwide, combining chemicals, equipment and software-enabled services. Long-term growth may be driven by rising water scarcity and hygiene standards, recurring consumables and service contracts, digital water and energy-efficiency solutions, and expansion in emerging markets, which could support steady revenues and margin improvement.
Primary risk is sensitivity to cyclical industrial and energy demand and input-cost volatility that can compress margins and reduce service volumes; investors should monitor regulatory and foreign-exchange exposure.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 2547.90M | 2571.20M | 1755.50M | 1343.40M | 1414.20M |
| Net income | 2075.60M | 2112.40M | 1372.30M | 1091.70M | 1129.90M |
| Gross profit | 7158.10M | 6843.00M | 6177.20M | 5426.70M | 5211.20M |
| Ebit | 2789.00M | 2909.60M | 2110.20M | 1849.00M | 1867.80M |
| Ebitda | 3461.60M | 3845.00M | 3033.80M | 2787.70M | 2710.90M |
| Depreciation and amortization | 672.60M | 935.40M | 923.60M | 938.70M | 843.10M |
| Operating income | 2912.60M | 2612.40M | 2160.70M | 1849.00M | 1867.80M |
| Other operating expenses | 13168.60M | 13129.00M | 13159.50M | 12600.80M | 11133.70M |
| Interest expense | 241.10M | 338.40M | 354.70M | - | 0.00M |
| Income tax expense | 454.60M | 439.30M | 362.50M | 234.50M | 270.20M |
| Total revenue | 16081.20M | 15741.40M | 15320.20M | 14187.80M | 12733.10M |
| Total operating expenses | 4245.50M | 4230.60M | 4016.50M | 3839.70M | 3611.80M |
| Cost of revenue | 8923.10M | 8898.40M | 9143.00M | 8761.10M | 7521.90M |
| Total other income expense net | -364.70M | -41.20M | -405.20M | -505.60M | -453.60M |
| Net income applicable to common shares | - | - | - | 1091.70M | 1129.90M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 24696.30M | 22387.80M | 21846.60M | 21464.30M | 21206.40M |
| Intangible assets | 3688.50M | 3308.80M | 3493.50M | 3680.70M | 4224.10M |
| Other current assets | 569.60M | 275.70M | 206.30M | 404.70M | 357.00M |
| Total liab | 14891.80M | 13598.60M | 13774.40M | 14205.70M | 13953.30M |
| Total stockholder equity | 9770.80M | 8757.30M | 8044.70M | 7236.10M | 7224.20M |
| Other current liab | 2459.00M | 2122.80M | 1753.40M | 2482.20M | 2169.00M |
| Common stock | 369.40M | 367.80M | 365.70M | 364.70M | 364.10M |
| Retained earnings | 12834.00M | 11517.10M | 10075.40M | 9318.80M | 8814.50M |
| Other liab | - | - | - | 1582.20M | 1770.30M |
| Good will | 9227.00M | 7907.30M | 8148.20M | 8012.70M | 8063.90M |
| Other assets | - | - | 0.00M | 535.10M | 546.00M |
| Cash | 646.20M | 1256.80M | 919.50M | 598.60M | 359.90M |
| Total current liabilities | 5534.70M | 4792.80M | 4345.80M | 4210.40M | 3553.20M |
| Current deferred revenue | - | 102.00M | 110.90M | - | - |
| Net debt | 8783.10M | 7025.90M | 7813.90M | -598.60M | -359.90M |
| Short term debt | 870.40M | 758.00M | 756.50M | - | - |
| Short long term debt total | 9429.30M | 8282.70M | 8733.40M | - | - |
| Other stockholder equity | -1558.30M | -1145.60M | -546.00M | -2447.40M | -1954.40M |
| Property plant equipment | - | - | - | 3741.60M | 3685.30M |
| Total current assets | 5955.60M | 6025.70M | 5644.10M | 5494.20M | 4687.10M |
| Net tangible assets | - | - | - | -4457.30M | -5063.80M |
| Net receivables | 3249.40M | 3028.30M | 3021.10M | 2698.10M | 2478.40M |
| Inventory | 1490.40M | 1464.90M | 1497.20M | 1792.80M | 1491.80M |
| Accounts payable | 2071.00M | 1810.00M | 1566.30M | 1728.20M | 1384.20M |
| Accumulated other comprehensive income | -1874.30M | -1982.00M | -1850.40M | - | - |
| Non currrent assets other | 782.70M | 469.80M | 389.80M | -15435.00M | -15973.30M |
| Non current assets total | 18740.70M | 16362.10M | 16202.50M | 15435.00M | 15973.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Change to liabilities | - | - | - | 394.70M | 200.40M |
| Total cashflows from investing activities | -2707.20M | -433.80M | -990.50M | -716.80M | -4579.70M |
| Net borrowings | - | - | - | 89.70M | 2121.30M |
| Total cash from financing activities | -853.30M | -2024.10M | -1054.70M | -837.30M | 1603.20M |
| Change to operating activities | - | - | - | 51.10M | 51.40M |
| Net income | 2093.30M | 2131.90M | 1372.30M | 1091.70M | 1129.90M |
| Change in cash | -610.60M | 337.30M | 320.90M | 238.70M | -900.30M |
| Begin period cash flow | 1256.80M | 919.50M | 598.60M | 359.90M | 1260.20M |
| End period cash flow | 646.20M | 1256.80M | 919.50M | 598.60M | 359.90M |
| Total cash from operating activities | 2952.60M | 2813.90M | 2411.80M | 1788.40M | 2061.90M |
| Depreciation | 672.60M | 935.40M | 923.60M | 938.70M | 843.10M |
| Other cashflows from investing activities | -37.60M | -16.10M | -35.30M | 1.00M | -25.20M |
| Dividends paid | 753.60M | 664.30M | 617.30M | 602.80M | 566.40M |
| Change to inventory | 36.40M | -115.60M | 320.30M | -402.90M | -73.00M |
| Change to account receivables | -185.90M | -146.70M | -84.30M | -319.60M | -178.20M |
| Sale purchase of stock | -783.80M | -986.50M | -13.70M | -518.20M | -106.60M |
| Other cashflows from financing activities | -13.70M | 255.20M | 78.20M | 283.70M | 3323.50M |
| Change to netincome | - | - | - | 34.70M | 88.30M |
| Capital expenditures | 1048.30M | 994.50M | 774.80M | 712.80M | 643.00M |
| Change in working capital | -206.20M | 176.10M | 162.70M | -722.50M | -251.20M |
| Stock based compensation | 136.60M | 134.80M | 95.10M | 87.80M | 89.50M |
| Other non cash items | 289.70M | -373.80M | -86.20M | 392.70M | 250.60M |
| Free cash flow | 1904.30M | 1819.40M | 1637.00M | 1075.60M | 1418.90M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0IFA Ecolab Inc. |
2.87 0.99% |
292.00 | 0.70 | - | 4.73 | - |
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
| Name | Title | Year Born |
|---|---|---|
| Mr. Christophe Beck | CEO & Chairman | 1968 |
| Mr. Daniel J. Schmechel | Exec. Officer | 1960 |
| Mr. Timothy P. Mulhere | Exec. VP and Pres of Global Institutional & Specialty Services | 1963 |
| Ms. Angela M. Busch | Exec. VP of Corp. Strategy & Bus. Devel. | 1967 |
| Mr. Darrell R. Brown | Pres & COO | 1964 |
| Mr. Scott D. Kirkland | Chief Financial Officer | 1974 |
| Ms. Jennifer J. Bradway | Sr. VP, Corp. Controller & Principal Accounting Officer | 1977 |
| Dr. Larry L. Berger | Exec. VP & CTO | 1961 |
| Mr. David Bingenheimer | Exec. VP & Chief Information Officer | NA |
| Mr. Andrew Hedberg | Director of Investor Relations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.